MAR vs CVS
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MAR · Marriott International$416.47 ▼ 0.19%
CVS · CVS Health$83.85 ▲ 3.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MAR +44.6%
- CVS +10.7%
Head to head
| Metric | MAR | CVS |
|---|---|---|
| Price | $416.47 | $83.85 |
| Change today | ▼ 0.19% | ▲ 3.10% |
| Market cap | $107.24B | $107.28B |
| Return, 3 months | +19.8% | -12.4% |
| Return, year to date | +35.0% | +8.1% |
| Return, 1 year | +44.2% | +8.6% |
| P/E (TTM) | 41.5 | 9.7 |
| P/B | -21.1 | 1.3 |
| P/E percentile vs own 5y | 89th | 67th |
| Dividend yield | 0.67% | 3.17% |
| Revenue growth (YoY, latest qtr) | +4.8% | +7.3% |
| Net profit growth (YoY) | +0.4% | +195.7% |
| Gross margin | 20.1% | 14.2% |
| Operating margin | 15.7% | 3.4% |
| Net margin | 9.6% | 1.2% |
| Return on equity | – | 6.2% |
| Analyst target vs. price | 0.0% | +32.7% |
| Analyst buy share | 39% | 100% |
| RSI (14) | 70 | 40 |
| 30-day volatility | 23.5% | 47.4% |
| Max drawdown, 1 year | -18.2% | -27.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CVS is the largest of the group by market value.
- MAR has returned the most over the past year.
- CVS carries the lowest trailing P/E.
- CVS pays the highest dividend yield.
- CVS is growing revenue fastest.
- MAR keeps the most profit per dollar of sales.
- MAR has been the calmest stock over the last 30 days.